Acute Lymphoblastic Leukemia in a Patient Treated with Letrozole and Palbociclib
- Author:
Jin Hyun PARK
1
;
Hyunkyung PARK
;
Ki Hwan KIM
;
Jin Soo KIM
;
In Sil CHOI
;
Eun Youn ROH
;
Ji Eun KIM
;
Mee Soo CHANG
Author Information
- Publication Type:Case Report
- From:Journal of Breast Cancer 2020;23(1):100-106
- CountryRepublic of Korea
- Language:English
- Abstract: Palbociclib, in conjunction with endocrine therapy, has been approved for the treatment of patients with advanced breast cancer. The common hematological toxicities associated with palbociclib are leukopenia and neutropenia. However, hematological malignancies have not been reported for palbociclib treatment. Here, for the first time, we present a case of acute lymphoblastic leukemia that was diagnosed in a patient undergoing treatment with letrozole and palbociclib for metastatic breast cancer. This case emphasizes the need for long term follow up of patients treated with palbociclib.
